Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories to Host Virtual Investor Day

WILMINGTON, Mass.--(BUSINESS WIRE)--May 26, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced that it will host a virtual Meeting with Management on Thursday, May 27th, beginning at 8:30 a.m. ET.

This virtual event will feature presentations from its senior management team, including an overview of the Company’s strategic focus, business developments, and updated financial outlook, with a focus on its cell and gene therapy capabilities and the shift towards advanced therapeutics.

The webcast of this virtual event may be accessed through a link that is posted on the Investor Relations section of the Company's website at ir.criver.com. The associated slide presentation and reconciliations of GAAP financial measures to non-GAAP financial measures will also be posted on same website at approximately 8:00 a.m. ET on Thursday, May 27th. Following the event, a replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Investor Contact:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com

Media Contact:
Amy Cianciaruso
Corporate Vice President, Public Relations
781.222.6168
amy.cianciaruso@crl.com

Source: Charles River Laboratories International, Inc.

Featured Report

2020 Annual Report (PDF)

Charles River Corporate Citizenship Report
View PDF
Print PDF